BUSINESS INFORMATION |
products and services also take advantage of synergies in R&D, as well as in production and raw material use. The business, aimed at drug discovery and development, grew out of Co.`s well-established expertise in amines and its more recently developed biotechnological capabilities. Although market research had identified chiral intermediates and services as a viable market segment, the business began tentatively 10 years ago with a small facility in Ludwigshafen, Germany, and little investment. Now it is well received and commands three production plants |
PRODUCT | Fifteen compounds are now being produced in multiton scale, and scalable processes are in place for another 50 |
SERVICE | If a compound is not in the portfolio, Co. evaluates whether it can be made with its technology and raw materials, and if so, develops quantities required at various stages of drug development, he adds |
UPDATE | 07.02 |
COMPANY | This data is not available for free |
CONTACT | This data is not available for free |
LITERATURE REF. | This data is not available for free |
TRADEMARK | This data is not available for free |
Want more information ? Interested in the hidden information ? Click here and do your request. |